Compliance of postmenopausal osteoporotic and osteopenic patients with calcium and vitamin D therapy;Menopoz sonrası osteoporotik ve osteopenik hastaların kalsiyum ve vitamin D tedavisine uyumu

Eklem Hastaliklari ve Cerrahisi

Volumn 21, Issue 3, 2010, Pages 130-135

  Akkaya, Nuray ^a   Akkaya, Semih ^b   Yildiz, Necmettin ^a   Atalay, Nilgün Şimşir ^a   Şahin, Füsun ^a  

^a PAMUKKALE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^b Ortopedi ve Travmatoloji Anabilim Dali   (Turkey)

Author keywords

Calcium therapy; Compliance to medical therapy in osteoporosis; Osteopenia; Osteoporosis; Vitamin D therapy

Indexed keywords

CALCIUM; VITAMIN D;

ADULT; AGED; ARTICLE; EDUCATIONAL STATUS; FEMALE; HUMAN; METABOLIC BONE DISEASE; MIDDLE AGED; OSTEOPOROSIS; PATIENT COMPLIANCE; PATIENT EDUCATION; POSTMENOPAUSE;

ADULT; AGED; AGED, 80 AND OVER; BONE DISEASES, METABOLIC; CALCIUM; EDUCATIONAL STATUS; FEMALE; HUMANS; MIDDLE AGED; OSTEOPOROSIS; PATIENT COMPLIANCE; PATIENT EDUCATION AS TOPIC; POSTMENOPAUSE; VITAMIN D;

EID: 78649257404     PISSN: 13058282     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Rodríguez-Martínez MA, García-Cohen EC. Role of Ca(2+) and vitamin D in the prevention and treatment of osteoporosis. Pharmacol Ther 2002;93:37-49.
2. Sosa Henríquez M, Gómez de Tejada Romero MJ. Evidenced based medicine and drugs approved for the treatment of osteoporosis. Role of calcium and vitamin D. Rev Clin Esp 2009;209:25-36. [Abstract]
3. Ozkurt B, Ozkurt ZN, Altay M, Aktekin CN, Caǧlayan O, Tabak Y. The relationship between serum adipo-nectin level and anthropometry, bone mass, osteopo-rotic fracture risk in postmenopausal women. Eklem Hastalik Cerrahisi 2009;20:78-84.
4. Atik OS. Osteoporotik ki{dotless}ri{dotless}k riski hesaplanmasi{dotless}. Eklem Hastalik Cerrahisi 2008;19:1.
5. Boonen S, Rizzoli R, Meunier PJ, Stone M, Nuki G, Syversen U, et al. The need for clinical guidance in the use of calcium and vitamin D in the management of osteoporosis: a consensus report. Osteoporos Int 2004;15:511-9.
6. Nguyen TV, Center JR, Eisman JA. Osteoporosis: underrated, underdiagnosed and undertreated. Med J Aust 2004;180(5 Suppl):S18-22.
7. Lips P, Hosking D, Lippuner K, Norquist JM, Wehren L, Maalouf G, et al. The prevalence of vitamin D inadequacy amongst women with osteoporosis: an international epidemiological investigation. J Intern Med 2006;260:245-54.
8. Koster JC, Hackeng WH, Mulder H. Diminished effect of etidronate in vitamin D deficient osteopenic post-menopausal women. Eur J Clin Pharmacol 1996;51:145-7.
9. Castelo-Branco C, Cortés X, Ferrer M. Treatment persistence and compliance with a combination of calcium and vitamin D. Climacteric 2009. [Epub ahead of print]
10. Likert R. A technique for the measurement of attitudes. Archives of Psychology 1932;22:1-55.
11. Akan P, Erdinçler D, Tezcan V, Beǧer T. Yaşli{dotless}da ilaç kullani{dotless}mi{dotless}. Geriatri 1999;2:33-8.
12. Lanham-New SA. Importance of calcium, vitamin D and vitamin K for osteoporosis prevention and treatment. Proc Nutr Soc 2008;67:163-76.
13. Avenell A, Gillespie WJ, Gillespie LD, O'Connell DL. Vitamin D and vitamin D analogues for preventing fractures associated with involutional and post-meno-pausal osteoporosis. Cochrane Database Syst Rev 2005;3:CD000227.
14. Meunier P. Prevention of hip fractures by correcting calcium and vitamin D insufficiencies in elderly people. Scand J Rheumatol Suppl 1996;103:75-8.
15. Kanis JA, Burlet N, Cooper C, Delmas PD, Reginster JY, Borgstrom F, et al. European guidance for the diagnosis and management of osteoporosis in postmeno-pausal women. Osteoporos Int 2008;19:399-428.
16. Qaseem A, Snow V, Shekelle P, Hopkins R Jr, Forciea MA, Owens DK, et al. Pharmacologic treatment of low bone density or osteoporosis to prevent fractures: a clinical practice guideline from the American College of Physicians. Ann Intern Med 2008;149:404-15.
17. Boonen S, Vanderschueren D, Haentjens P, Lips P. Calcium and vitamin D in the prevention and treatment of osteoporosis - a clinical update. J Intern Med 2006;259:539-52.
18. Giusti A, Barone A, Razzano M, Oliveri M, Pizzonia M, Palummeri E, et al. Persistence with calcium and vitamin D in elderly patients after hip fracture. J Bone Miner Metab 2009;27:95-100.
19. Adami S, Isaia G, Luisetto G, Minisola S, Sinigaglia L, Gentilella R, et al. Fracture incidence and characterization in patients on osteoporosis treatment: the ICARO study. J Bone Miner Res 2006;21:1565-70.
20. International Osteoporosis Foundation. The adherence gap: why osteoporosis patients don't continue with treatment. Available from: http://www.iofbonehealth.org/publications/the-adherence-gap.html (Accessed 01.02.2010).
21. Romagnoli E, Colangeli I, Minisola S. Awareness, attitudes and opinions on osteoporosis of primary care physicians working in the metropolitan area of Rome: a brief report. Aging (Milano) 2000;12:240-4.
22. TM ve Türkiye (Osteoporotik ki{dotless}ri{dotless}k riski hesaplanmasi{dotless}). Eklem Hastalik Cerrahisi 2008;19:100.
23. Has R, İyibozkurt C, Yi{dotless}ldi{dotless}ri{dotless}m A. Osteoporozun önlen-mesi ve tedavisinde yeni gelişmeler. T Fiz Ti{dotless}p Reh Derg 1999:2:58-63.
24. Atik OS, Suluova F, Görmeli G, Yildirim A, Ali AKh. Insufficiency femoral fractures in patients undergoing prolonged alendronate therapy. Eklem Hastalik Cerrahisi 2010;21:56-9.